Manandhar, Priyanka
(2024)
Tim-3: Regulation of T Cell Functions and Mechanism of Expression.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
Tim-3 is a transmembrane protein that is commonly used as a marker for terminally exhausted CD8+ T cells in the contexts of chronic infections and tumors. However, Tim-3 is widely expressed on Th1 CD4+ T cells, regulatory T cells, dendritic cells and mast cells, in addition to activated CD8+ T cells. While Tim-3 has been shown to induce death in Th1 cells, it is co- stimulatory in T cells during acute stimulation and has been shown to activate the PI3K pathway. The germline deletion of Tim-3 in mice was previously shown to skew the CD8+ T cell response towards a memory phenotype in the context of LCMV Armstrong infection but the effects of Tim- 3 on CD8+ T cells at the effector stage of the infection remain unknown. In addition, it is not known whether different transcription factors regulate the expression of Tim-3 in conditions of acute vs. chronic stimulation. The transcription factor Blimp-1 has also been shown to co-express with Tim- 3 in acute and chronic infections. Although there are no predicted Blimp-1 binding sites in the Havcr2 locus, there are binding sites for E2A, leading us to predict that a Blimp-1-Id3-E2A transcription factor circuit may play a role in Tim-3 expression.
Using TIRF imaging, I have shown here that Tim-3 localizes to the immunological synapse during T cell activation. Using a novel Tim-3 truncation mutant and a CD8-specific knockout mouse model, I have also shown that Tim-3 is required for a robust CD8+ effector T cell response to LCMV Armstrong and Tim-3 expressing effector CD8+ T cells have an enhanced effector-like phenotype. Additionally, Blimp-1 and Id3 conditional knockout mice in chronic and acute infections show that Blimp-1 and Id3 regulate the expression of Tim-3 in CD8+ T cells.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
14 October 2024 |
Date Type: |
Publication |
Defense Date: |
12 April 2024 |
Approval Date: |
14 October 2024 |
Submission Date: |
1 May 2024 |
Access Restriction: |
2 year -- Restrict access to University of Pittsburgh for a period of 2 years. |
Number of Pages: |
157 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Immunology |
Degree: |
PhD - Doctor of Philosophy |
Thesis Type: |
Doctoral Dissertation |
Refereed: |
Yes |
Uncontrolled Keywords: |
CD4 and CD8 T cells, T cell activation, T cell response to LCMV |
Date Deposited: |
14 Oct 2024 14:22 |
Last Modified: |
14 Oct 2024 14:22 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/46378 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |